A phenotypic screen to identify hypertrophy-modulating microRNAs in primary cardiomyocytes

Area of Science:

• Cardiovascular Biology
• Molecular Biology
• Biotechnology

Background:

• MicroRNAs (miRNAs) are increasingly linked to cardiac diseases, but functional data is scarce.
• Current understanding of most miRNAs' roles in heart conditions is limited due to a lack of functional studies.
• Dysregulation of miRNAs in diseased heart tissue suggests potential roles, but direct evidence is often missing.

Purpose of the Study:

• To develop and validate a high-throughput assay for assessing miRNA function in primary cardiomyocytes.
• To identify novel miRNAs that regulate cardiomyocyte size and hypertrophy.
• To investigate the relationship between miRNA expression levels and their phenotypic effects on cardiomyocytes.

Main Methods:

• Development of an automated microscopy assay for quantifying cardiomyocyte size.
• Utilized an edge detection algorithm for robust and reproducible cell size assessment.
• Screened a library of synthetic miRNAs for their impact on cardiomyocyte hypertrophy.

Main Results:

• Identified several previously unrecognized pro-hypertrophic miRNAs (miR-22, miR-30c, miR-30d, miR-212, miR-365) and anti-hypertrophic miRNAs (miR-27a, miR-27b, miR-133a).
• Confirmed the phenotypic effects of nine selected miRNAs on cardiomyocyte hypertrophy.
• Observed a low correlation between the expression levels of pro-hypertrophic miRNAs and their observed effects.

Conclusions:

• The developed assay enables automated assessment of cardiomyocyte size and identification of miRNA regulators.
• Discovered novel miRNAs that modulate cardiomyocyte hypertrophy, expanding the known miRNA landscape in cardiac biology.
• Further research into the mechanisms of these identified miRNAs can elucidate pathways involved in cardiac hypertrophy.